Table 1.
Baseline characteristics of the patients
| Variables at baseline | n (%) |
| Total number | 148 |
| Median age (yr) | 50.13 ± 13.55, (14-78) |
| Sex ratio (M:F) | 108:40 |
| Underlying cause | |
| Viral hepatitis B | 87 (58.8) |
| Viral hepatitis C | 7 (4.7) |
| Alcoholic cirrhosis | 14 (9.4) |
| Primary biliary cirrhosis | 6 (4.1) |
| Drug-induced liver cirrhosis | 2 (1.3) |
| Budd-Chiari syndrome | 3 (2.0) |
| CTPV | 4 (2.7) |
| Wilson’s disease | 1 (0.67) |
| Unknown etiology | 24 (16.2) |
| Association with other diseases | |
| Type-2 diabetes | 16 (10.8) |
| Primary hepatic carcinoma | 12 (8.1) |
| Hypertensive disease | 9 (6.1) |
| Portal vein thrombogenesis | 3 (2.0) |
| Clinical classification | |
| Isolated GV | 30 (20.3) |
| EGV received EVS or EVL | 72 (48.6) |
| Residual GV after EVS or EVL | 20 (13.5) |
| GV bleeding after disconnection | 18 (12.2) |
| Other condition | 8 (5.4) |
| Sarin’s category (%) | |
| GOV-1 | 68 (45.9) |
| GOV-2 | 49 (33.1) |
| IGV-1 | 30 (20.3) |
| IGV-2 | 1 (0.67) |
| Child-Pugh class | |
| A/B/C | 42/73/33 |
GV: Gastric varices; EGV: Esophagogastric variceal; GOV: Gastroesophageal varices; IGV: Isolated gastric varices; CTPV: Cavernous transformation of the portal vein.